ArticleGastro hep advances2025
Double-Strand Breaks Induce Nuclear-Cytosolic Shuttling of Polymorphic DNA Mismatch Repair Protein MutS Homolog 3 and Binding to NEMO/IKKγ in Colon Cancer Cells.
Article in Gastro hep advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prevalence of germline MSH3 polymorphisms in ulcerative colitis and early-onset colorectal cancer patients that potentiates inflammation-to-cancer transformation.Human molecular genetics · 2026Article
- Synthetic Integration of an FCS into Coronaviruses-Hype or an Unresolved Biorisk? An Integrative Analysis of DNA Repair, Cancer Research, Drug Development, and Escape Mutant Traits.Life (Basel, Switzerland) · 2026Article
- Inflammation Drives Phosphorylation and Acetylation of MutS Homolog 3 and Interaction with Cytosolic HDAC6.Journal of Cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Background and Aims: Human MutS homolog 3 (MSH3) is a DNA mismatch repair protein that recognizes postsynthetic slippage mistakes at microsatellite sequences consisting of dinucleotide or longer repeats in concert with its heterodimer partner MSH2. MSH3 has also been implicated in DNA double-strand break (DSB) repair as part of Homologous Recombination. Loss of MSH3 function is an acquired somatic defect seen in 50% of colorectal cancers and triggered by proinflammatory interleukin-6 signaling, causing a reversible nuclear-to-cytoplasmic shift of the protein. With MSH3's shift to the cytosol, microsatellite frameshift mutations accumulate. Here we examined MSH3 and Δ27bpMSH3, an MSH3 polymorph that alters function of MSH3's nuclear localization signal with enhancement for cytosolic retention with interleukin-6 and oxidative stress, for evidence of dysfunction with induced DSBs. Methods: We employed immunofluorescent microscopy, nuclear-cytosolic protein fractionation, immunoprecipitation and quantitative reverse transcriptase polymerase chain reaction to track the location and amount of MSH3 and Δ27bpMSH3 after inducing DSBs with etoposide. Results: Cells containing polymorphic Δ27bpMSH3 were more susceptible to induced DSBs, and induced DSBs triggered nuclear-to-cytosolic shift of Δ27bpMSH3 that involved binding to the NFκB protein NEMO/IKKγ. Conclusion: These findings suggest that inflammatory proteins are important for Δ27bpMSH3 translocation to the cytosol but also for stabilizing MSH3 when separated from nuclear MSH2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.